0001209191-23-035825.txt : 20230609
0001209191-23-035825.hdr.sgml : 20230609
20230609162034
ACCESSION NUMBER: 0001209191-23-035825
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fischer Seth H. Z.
CENTRAL INDEX KEY: 0001573553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 231005566
MAIL ADDRESS:
STREET 1: C/O TRIUS THERAPEUTICS, INC.
STREET 2: 6310 NANCY RIDGE DRIVE, SUITE 101
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER NAME:
FORMER CONFORMED NAME: Fischer Seth H.Z.
DATE OF NAME CHANGE: 20130402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-07
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001573553
Fischer Seth H. Z.
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTREAL
A8
H4M 2X6
QUEBEC, CANADA
1
0
0
0
0
Stock Option (right to buy)
3.86
2023-06-07
4
A
0
30000
0.00
A
2033-06-07
Common Shares
30000
30000
D
This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.
/s/ Jason Minio, Attorney-in-Fact
2023-06-09